Akanda (AKAN) Shares Outstanding (Diluted Average) (2020 - 2025)
Akanda (AKAN) recorded quarterly Shares Outstanding (Diluted Average) of $1170.0 in Q2 2025, down 93.41% quarter-over-quarter from $17760.0 in Q2 2024, and down 93.41% on a YoY basis from $17760.0 in Q2 2024.
Akanda (AKAN) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends
Akanda's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $1170.0 for Q2 2025.
- In Q2 2025, Shares Outstanding (Diluted Average) fell 93.41% year-over-year to $1170.0; the TTM figure through Jun 2025 stood at $1170.0 (down 93.41% YoY), while the FY2020 annual figure was $13.1 million, changed 0.0% from the prior year.
- Shares Outstanding (Diluted Average) was $1170.0 for Q2 2025 at Akanda, down from $17760.0 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $58350.0 in Q2 2023 to a low of $40.0 in Q2 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $19330.0 across 4 years, with a median of $9465.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) surged 145775.0% in 2023, then slumped 93.41% in 2025.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $40.0 in 2022, then soared by 145775.0% to $58350.0 in 2023, then plunged by 69.56% to $17760.0 in 2024, then plunged by 93.41% to $1170.0 in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $1170.0 (Q2 2025), $17760.0 (Q2 2024), and $58350.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Akanda | 826.99 Mn | 824.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,170.00 |
| Jun 30, 2024 | 17,760.00 |
| Jun 30, 2023 | 58,350.00 |
| Jun 30, 2022 | 40.00 |
| Dec 31, 2020 | 13.13 Mn |